Data / Drug companies / Felodipine
Felodipine: 15 companies and 50 products in the FDA NDC directory
Felodipine is listed in the FDA National Drug Code Directory by 15 companies, with 50 products in commercial distribution. 50 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated, extended release; tablet, film coated, and the newest product started marketing on March 31, 2023.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 50
- Generic (ANDA) products
- 50 (100.0%)
- Application numbers
- 7
- Routes
- Oral
- Brand names
- Felopdipine
- openFDA record search
- api.fda.gov
Companies that list felodipine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 6 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | October 12, 2020 |
| Bryant Ranch Prepack | 6 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | October 12, 2020 |
| A-S Medication Solutions | 3 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | March 31, 2023 |
| Aurobindo Pharma Limited | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | January 17, 2013 |
| Bryant Ranch Prepack | 3 | tablet, film coated, extended release; tablet, film coated | Generic drugs (ANDA) | October 12, 2020 |
| Carlsbad Technology, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 12, 2020 |
| Chartwell RX, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | August 1, 2019 |
| Glenmark Pharmaceuticals Inc., USA | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | December 20, 2010 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | November 8, 2013 |
| Par Health USA, LLC | 3 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | December 15, 2011 |
| Proficient Rx LP | 3 | tablet, film coated | Generic drugs (ANDA) | October 12, 2020 |
| Rising Pharma Holdings, Inc. | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | January 17, 2013 |
| Torrent Pharmaceuticals Limited | 3 | tablet, extended release | Generic drugs (ANDA) | November 28, 2011 |
| Westminster Pharmaceuticals, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | March 31, 2023 |
| Golden State Medical Supply, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | April 29, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 20 | 40% |
| Tablet, film coated, extended release | 15 | 30% |
| Tablet, film coated | 15 | 30% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 50 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Dihydropyridine Calcium Channel Blocker | 50 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.